日本語 
Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the next stage in Europe. The European Medicines Agency has validated the application. That basically means the file is…
Gunze Medical signs Japan distribution deal with HistoSonics
Gunze Limited, based in Osaka, Japan, announced that its subsidiary, Gunze Medical…
Olympus Launches SecureFlex Single-Use Biopsy Device
Olympus Corporation has launched SecureFlex. This is a single-use fine needle biopsy…
Rentschler Biopharma Expands in Japan and Korea
Rentschler Biopharma SE, a leading global CDMO for biopharmaceuticals, is boldly expanding…
Eisai and Biogen introduce LEQEMBI IQLIK for Alzheimer
Eisai Co., Ltd. and Biogen Inc. LEQEMBI® IQLIK™ (lecanemab-irmb) is now available…
Japan’s Digital Therapeutics Market Poised for Takeoff — What It Means for Tech Players
Japan is quietly becoming one of Asia’s most promising frontiers for digital…
Doctors and Nankodo Form Alliance for AI Medical Platform
Doctors, Inc., a leading provider of comprehensive digital health solutions from service…
Kensapo Health Service Raises ¥800M in Series A Funding
Personal Health Tech Inc., which operates "Kensapo," a service that supports corporate…
Elix, an AI Drug Discovery Company, and Tohoku University Enter Joint Research Agreement to Advance AI Drug Discovery
Elix, Inc. and the Graduate School of Life Sciences at Tohoku University…
English